The GLP is committed to full transparency. Download and review our 2019 Annual Report

Viewpoint: We can stop the infertility ‘guessing game’ by tapping into new tools, including noninvasive testing for endometriosis

| | November 14, 2019

This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Without understanding the root cause of infertility, treating it often becomes a guessing game. For doctors to effectively aid a couple along the path to conception, they need to understand every factor that is standing in their way. One factor that is notoriously difficult to diagnose is endometriosis, which affects one in 10 women.

Noninvasive testing to diagnose endometriosis and other factors of infertility would allow and empower women to learn of their disease earlier, take the necessary steps to manage it and protect their fertility before it is irreparably harmed. Early diagnosis can improve not only patients’ physical health but also their mental and emotional wellbeing. Through more advanced genetic diagnostics, couples may achieve pregnancy more easily and produce healthier children. Noninvasive and effective diagnostic tools—such as ARTguide, for example, a blood test that tests for genetic factors of infertility including endometriosis and ovulation issues—could allow for a deeper level of understanding around the challenge of conception.

Related article:  Mind or matter? How consciousness in the universe could be ‘eternal’

Technology is advancing at an unprecedented rate, and in order to give patients the best possible care, doctors need to tap into the latest tools.

Read full, original post: Are We Doing Everything We Can to Treat Infertility?

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend